CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net Income (Loss)	$ 41,577	$ 185,959	$ 128,291
Adjustments to reconcile net income to net cash provided by operating activities:
Inventory step-up charges	1,238	0	2,130
Depreciation and amortization	68,085	50,985	38,447
Amortization of debt discount and issuance costs	2,448	1,815	11,530
Stock-based compensation	25,575	27,316	27,500
Deferred income taxes, net	2,317	(1,352)	6,517
Contingent consideration	(30,569)	(28,729)	5,865
Non-cash interest income	(2,023)	0	0
Loss on extinguishment of debt	12,676	0	0
Other	1,231	(100)	864
Changes in operating assets and liabilities, excluding impact of acquisitions:
Accounts receivable	(3,312)	(3,596)	(46,523)
Inventories	40,973	(57,204)	(89,781)
Prepaid expenses and other assets	(13,030)	2,396	(10,192)
Operating lease right of use assets	14,059	(24,549)	(4,315)
Other assets	(461)	(231)	430
Accounts payable	(9,803)	(8,197)	19,523
Accrued expenses	(27,921)	(2,019)	23,196
Operating lease liability	(9,229)	28,623	6,958
Long-term liabilities	87	966	(1,424)
Total cash provided by operating activities	113,918	172,083	119,016
Cash flows from investing activities:
Purchase of marketable securities held to maturity	0	(100,000)	0
Redemption of marketable securities	102,323	0	0
Additions to capitalized software costs	(2,766)	(3,512)	(4,187)
Acquisitions, net of cash acquired	(186,642)	0	(149,893)
Purchases of property, plant and equipment	(36,222)	(84,834)	(67,089)
Purchase of intellectual property	0	(45,000)	0
Other investing activities	32	110	0
Total cash used in investing activities	(123,275)	(233,236)	(221,169)
Cash flows from financing activities:
Repurchase of common stock	(14,386)	0	0
Proceeds from issuance of 2023 Convertible Senior Notes	290,094	0	0
Proceeds from exercise of stock options	1,076	3,707	3,879
Payment of debt issuance costs	(7,253)	0	0
Payment of tax withholding obligation on vesting of restricted stock	(13,227)	(17,018)	(2,897)
Payment of earnout consideration	(7,298)	0	0
Other financing activities	(45)	(26)	(21)
Total cash provided by (used in) financing activities	248,961	(13,337)	961
Effect of exchange rate changes on cash and cash equivalents	(11,739)	(5,866)	(12,286)
Net increase (decrease) in cash and cash equivalents	227,865	(80,356)	(113,478)
Cash and cash equivalents, beginning of period	523,458	603,814	717,292
Cash and cash equivalents, end of period	751,323	523,458	603,814
Supplemental disclosure of cash flow information:
Income taxes paid	26,963	34,365	16,515
Interest paid	988	1,033	1,066
Supplemental disclosure of non-cash investing and financing activities:
Assets acquired under operating leases	4,335	29,126	85,312
Fair value of shares of common stock issued for acquisitions	13,569	0	82,968
Fair value of shares of common stock issued for contingent consideration earnouts	7,229	0	0
Acquisition date fair value of contingent consideration earnouts	6,640	0	88,373
Issuance of 2023 Notes in exchange of 2019 Notes	42,179	0	0
Extinguished 2019 Notes	$ 29,634	$ 0	$ 0